Gastrointestinal cancer metastatic – Basic Information

Go back

Gastrointestinal cancer metastatic refers to cancers that begin in the digestive system and spread to other parts of the body. This condition represents one of the most challenging aspects of gastrointestinal cancers, as the spread of cancer cells significantly impacts treatment options and patient outcomes.

Understanding Gastrointestinal Cancer Metastasis

When cancer cells from the gastrointestinal tract spread beyond their original location to distant organs, the disease becomes metastatic. This process, known as metastasis (the spread of cancer cells from where they started to other parts of the body), marks an advanced stage of the disease. The poor outlook associated with gastrointestinal cancers is largely due to this spreading behavior, which represents the biological hallmark of malignant tumors.[1]

Gastrointestinal cancers can originate in various organs including the stomach, esophagus, liver, pancreas, small intestine, large intestine (colon), rectum, bile ducts, and gallbladder. When these cancers spread, they follow specific patterns, typically targeting certain organs first before moving to others.[6]

The spreading process happens in multiple steps. Cancer cells must first grow into or invade nearby normal tissue, then move through the walls of nearby blood vessels or lymph nodes. These cells travel through the body’s circulatory systems, stop in small blood vessels at distant locations, invade the blood vessel walls there, and finally settle into surrounding tissue where they form new tumors.[4]

Where Gastrointestinal Cancers Spread

Gastrointestinal cancers show predictable patterns in where they spread. The most common sites for metastasis include the liver, lymph nodes, peritoneum (the tissue lining the abdominal cavity), and subsequently the lungs and other body sites. This spread, whether occurring in a single location or multiple areas, represents the major cause of deaths related to gastrointestinal cancer.[1]

For stomach cancer specifically, when the disease spreads beyond the stomach it commonly affects the liver, lymph nodes, the tissue lining the abdominal cavity, and lungs.[3] Similarly, other gastrointestinal cancers follow comparable patterns, with the liver being a particularly frequent destination for cancer cells originating from digestive organs.[4]

The cancer maintains the characteristics of its original location even after spreading. For example, stomach cancer that spreads to the liver is still called metastatic stomach cancer, not liver cancer. Under a microscope and through testing, these cancer cells show features of the primary stomach cancer rather than the organ where they have settled.[4]

⚠️ Important
Sometimes cancer is already advanced when first diagnosed, or it may come back and spread after treatment for the original cancer. When gastrointestinal cancer has spread to distant parts of the body, it is typically classified as stage 4 in the number staging system. Unfortunately, advanced cancer at this stage usually cannot be cured, though treatment can control it, help manage symptoms, and improve quality of life for some time.

Epidemiology and Disease Patterns

Gastric cancer, one of the major gastrointestinal cancers, ranks as the fifth most common malignant tumor and the fourth leading cause of cancer-associated death worldwide. The disease shows significant geographical variation, with the highest rates occurring in Eastern Asia, particularly Japan and Mongolia, and in Eastern Europe. In contrast, Northern Europe and Northern America show generally low incidence rates, comparable to those in African regions.[12]

In the United States, gastric cancer ranks fifteenth in incidence among major cancer types. Estimated new cases of gastric cancer in 2025 total 30,300, with approximately 10,780 deaths expected.[10] Despite representing a relatively small percentage of overall cancer diagnoses in the US, accounting for about 1.5% of all cancers diagnosed yearly, the disease carries serious implications when it spreads.[2]

Most patients unfortunately receive their diagnosis at advanced stages, partly due to subtle symptoms in earlier disease and low rates of regular screening. This late diagnosis means that many people already have metastatic disease when they first seek medical care. In the United States, early-stage disease accounts for only 10% to 20% of all diagnosed cases, with the remaining patients presenting with cancer that has spread to either regional or distant sites.[10]

The demographic patterns show that stomach cancer more commonly affects older individuals, with an average age at diagnosis of 68 years. Around 60% of cases occur in patients older than 65, and men face a slightly higher lifetime risk of developing stomach cancer compared to women.[2]

Interestingly, recent years have seen a progressive rise in gastric cancer incidence among young adults (aged less than 50 years) in both low-risk and high-risk countries, representing a concerning shift in disease patterns.[12]

Causes and Development

Stomach cancer develops when small changes occur in the DNA of stomach cells, instructing them to multiply excessively. These abnormal cells accumulate over time, forming growths called tumors. The disease tends to develop slowly, usually over many years rather than appearing suddenly.[2]

While the precise cause remains unknown, scientists have identified several factors that play important roles. Infection with Helicobacter pylori (a type of bacteria that can infect the stomach) stands as a significant contributor to gastric cancer development. This bacterial infection can lead to chronic inflammation and changes in the stomach lining over time.[10]

The mechanisms behind how cancer becomes metastatic involve complex cellular and molecular processes. These include local growth of new blood vessels that feed the tumor, variations among cancer cells (called heterogeneity), complex signaling pathways that cancer cells use to communicate and grow, and decreased expression of molecules that normally help cells stick together, such as E-cadherin. Understanding and blocking these molecular pathways provides promising perspectives in fighting gastrointestinal cancer spread.[1]

The relationship between the surrounding tissue environment (called the stromal microenvironment) and where cancer decides to spread represents an interesting area of ongoing research. Scientists are also studying the role of cancer stem cells in metastasis and trying to understand whether cancer cells are born with the ability to spread or whether they acquire this ability over time.[1]

Risk Factors

Several acknowledged risk factors increase the likelihood of developing gastric cancer. Advanced age represents a significant factor, as the disease predominantly affects older individuals. Male sex also confers higher risk compared to females.[10]

Dietary habits play a substantial role in risk. A diet low in fruits and vegetables or high in salted, smoked, or preserved foods increases the chances of developing stomach cancer. These dietary patterns have been associated with higher cancer rates across different populations.[10]

Certain stomach conditions elevate risk considerably. Chronic atrophic gastritis (long-term inflammation of the stomach lining that causes the lining to thin), intestinal metaplasia (when stomach lining cells change to resemble intestinal cells), pernicious anemia (a condition where the body cannot properly absorb vitamin B12), and gastric adenomatous polyps (growths in the stomach lining) all increase susceptibility to cancer development.[10]

Lifestyle factors also matter. Cigarette smoking significantly increases risk, as does alcohol consumption. A family history of gastric cancer suggests possible genetic predisposition. Certain rare conditions like Ménétrier disease (also called giant hypertrophic gastritis) and Epstein-Barr virus infection have been linked to increased cancer risk.[10]

Familial syndromes, including familial adenomatous polyposis, can predispose individuals to gastrointestinal cancers. Besides Helicobacter pylori infection, genetic risk factors and lifestyle factors work together to influence overall disease occurrence.[12]

Symptoms of Metastatic Gastrointestinal Cancer

Metastatic cancer does not always cause symptoms immediately. When symptoms do appear, their nature and frequency depend on the size and location of the tumors that have spread to other parts of the body.[4]

For metastatic stomach cancer specifically, several symptoms commonly occur. These include indigestion or heartburn, abdominal bloating, nausea, loss of appetite, blood in the stool, vomiting, unintentional weight loss, abdominal pain, and problems swallowing (called dysphagia).[5]

When cancer spreads to specific organs, it produces symptoms related to those locations. Cancer that has spread to the liver may cause jaundice (yellowing of the eyes or skin) or ascites (fluid buildup in the abdomen). When cancer reaches the bones, it can cause bone pain and fractures. Spread to the brain may result in headaches, seizures, or dizziness. If cancer involves the lungs, shortness of breath becomes a prominent symptom.[4][5]

A blocked bowel represents a serious complication that can occur when tumors in the abdominal area grow large enough to completely obstruct the intestines. This bowel obstruction prevents digested food waste from passing through normally. Cancers can also stop the bowel from working properly by pressing on the muscles, nerves, or gut lining. Symptoms of bowel obstruction include feeling bloated and full, pain, feeling sick, vomiting large amounts, and constipation.[16]

The rapid progression of unresectable gastrointestinal cancer and associated malnutrition significantly impact a patient’s quality of life and ability to tolerate treatment. Up to 70% of people with advanced cancer experience nausea and vomiting, though these symptoms may have multiple causes not always directly linked to the cancer itself.[16][18]

Prevention Strategies

While there is no definitive way to prevent stomach cancer from spreading once it has developed, researchers are studying mechanisms that might help interrupt the metastatic process. Scientists are investigating something called a pre-metastatic niche, which refers to how a primary tumor sends signals through the bloodstream that affect cells in distant sites, creating an environment that supports arriving cancer cells.[5]

Certain lifestyle factors can help the body fight stomach cancer more effectively. Reaching or maintaining a moderate weight provides health benefits. Stopping smoking, if applicable, represents an important step. Eating a balanced diet rich in fresh fruits and vegetables supplies nutrients that support overall health and may help the body’s natural defenses.[5]

For people at higher risk of developing gastrointestinal cancers, being aware of risk factors and taking steps to address modifiable ones makes sense. This includes managing Helicobacter pylori infections if detected, avoiding diets high in salted, smoked, or preserved foods, and increasing consumption of fresh fruits and vegetables.[10]

Pathophysiology: How the Body Changes

Understanding what happens inside the body when gastrointestinal cancer becomes metastatic helps explain why the disease behaves as it does. The pathophysiology involves changes at cellular, tissue, and organ levels that alter normal body functions.

The prognosis of patients with gastric cancer relates directly to tumor extent, including both lymph node involvement and direct tumor extension beyond the stomach wall. Tumor grade, which describes how abnormal the cancer cells look under a microscope, may also provide prognostic information. In localized distal gastric cancer (cancer in the lower part of the stomach that hasn’t spread), more than 50% of patients can potentially be cured. However, early-stage disease accounts for only a small fraction of cases diagnosed in the United States.[10]

When examining stomach cancer specifically, the disease can be grouped into different types based on where it occurs. In the United States, most stomach cancers occur in the gastroesophageal junction, where the esophagus meets the stomach. Different patterns have emerged over time regarding cancer location, with some areas showing decreased occurrence while others show increases in certain age groups.[2][10]

The stomach consists of different layers of tissues, and the stage of cancer often depends on which layer the tumor has grown into. Cancer begins in the inner lining and can progressively invade deeper layers, eventually breaking through to spread to nearby organs or distant sites through the lymphatic system and bloodstream.[7]

Metastatic cancer cells can remain inactive at a distant site for many years before they begin growing again, if they grow at all. This dormancy period represents one of the mysteries of cancer biology that researchers continue to study. Most of the time, spreading cancer cells die at some point during their journey through the body. However, as long as conditions remain favorable at every step, some cells succeed in forming new tumors in other body parts.[4]

⚠️ Important
For patients with metastatic disease, cure is rarely achieved. The treatment goal shifts to prolonging life and improving quality of life for as long as possible. The five-year overall survival rate varies dramatically depending on disease extent, ranging from almost no survival for patients with widely disseminated disease to nearly 50% survival for patients with localized disease confined to removable regional areas. Early diagnosis and effective treatment remain vitally important and may lead to substantial extension of life expectancy.

Ongoing Clinical Trials on Gastrointestinal cancer metastatic

  • Chemotherapy Dose Adjustment for Gastrointestinal Cancer Patients with DPD Deficiency Using Fluorouracil, Capecitabine, and Oxaliplatin

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

    Not yet recruiting

    1 1 1
    Germany
  • Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Czechia France Germany Hungary Ireland +6
  • Study on the Safety and Efficacy of CR6086 and Balstilimab for Patients with Pretreated Metastatic Colorectal and Other GI Cancers

    Not recruiting

    1 1
    Investigated drugs:
    Italy
  • Study of Retifanlimab, Capecitabine, and Oxaliplatin for First-Line Treatment in Patients with Metastatic Esophagogastric Cancer

    Not recruiting

    1 1
    Investigated drugs:
    The Netherlands
  • Study of Romiplostim Treatment for Chemotherapy-induced Low Blood Platelets in Adults with Gastrointestinal, Pancreatic, or Colorectal Cancer Receiving Oxaliplatin Chemotherapy

    Not recruiting

    1 1 1
    Investigated drugs:
    Bulgaria France Greece Italy Poland Portugal +2

References

https://pmc.ncbi.nlm.nih.gov/articles/PMC3539350/

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/symptoms-causes/syc-20352438

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/advanced-cancer/about-advanced-cancer

https://www.cancer.gov/types/metastatic-cancer

https://www.medicalnewstoday.com/articles/metastatic-stomach-cancer

https://cancer.stonybrookmedicine.edu/GICancer/Types

https://cancer.ca/en/cancer-information/cancer-types/stomach/staging

https://www.tgh.org/institutes-and-services/conditions/gastrointestinal-cancer

https://pmc.ncbi.nlm.nih.gov/articles/PMC3983446/

https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-023-01451-3

https://www.mskcc.org/cancer-care/types/colon/treatment/metastases

https://cancer.ca/en/cancer-information/cancer-types/stomach/treatment/stage-4-and-recurrent

https://pmc.ncbi.nlm.nih.gov/articles/PMC4631965/

https://www.cancerresearchuk.org/about-cancer/coping/physically/sickness/controlling-sickness-in-advanced-cancer

https://www.cancerresearchuk.org/about-cancer/bowel-cancer/metastatic/coping-support

https://pmc.ncbi.nlm.nih.gov/articles/PMC11120513/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can metastatic gastrointestinal cancer be cured?

Unfortunately, advanced cancer that has spread to distant parts of the body usually cannot be cured. However, treatment can control the disease, help manage symptoms, and improve quality of life for some time. In a very small number of cases where cancer has spread to just one other body part and surgeons can completely remove both the original cancer and the metastasis, cure might be possible.

How is metastatic gastrointestinal cancer different from early-stage cancer?

Metastatic gastrointestinal cancer means the disease has spread from its original location in the digestive system to other parts of the body, such as the liver, lungs, or lymph nodes. It is classified as stage 4 cancer. Early-stage cancer remains confined to its original location or nearby tissues and has better treatment outcomes, with cure possible in many cases.

What organs does gastrointestinal cancer usually spread to first?

Gastrointestinal cancers most commonly spread to the liver, lymph nodes, and the peritoneum (the tissue lining the abdominal cavity) first. Subsequently, the lungs and other body sites may become involved. The liver is particularly vulnerable as it filters blood from the digestive organs.

Why is metastatic gastrointestinal cancer often diagnosed late?

Most patients are diagnosed at advanced stages because early gastrointestinal cancers often cause subtle or no symptoms. The lack of distinguishing clinical signs in early disease, combined with low rates of regular screening in many populations, means cancer may not be detected until it has already spread.

Does metastatic stomach cancer change into the type of cancer where it spreads?

No. Cancer maintains the characteristics of its original location even after spreading. For example, stomach cancer that spreads to the liver is still called metastatic stomach cancer, not liver cancer. Under a microscope, these cancer cells show features of stomach cancer rather than the organ where they have settled, which is how doctors identify where the cancer originally started.

🎯 Key takeaways

  • Metastatic gastrointestinal cancer represents advanced disease where cancer has spread from digestive organs to distant body parts, primarily the liver, lymph nodes, peritoneum, and lungs.
  • The poor prognosis of gastrointestinal cancers is largely due to metastasis, which is the major cause of cancer-related deaths in this group of diseases.
  • Most patients receive their diagnosis at advanced stages because early symptoms are subtle and regular screening rates remain low, with only 10-20% of US cases detected at early, more treatable stages.
  • Cancer cells that spread can lie dormant at distant sites for many years before growing, and most spreading cells actually die during their journey—only a small fraction succeed in forming new tumors.
  • Primary tumors cleverly prepare distant organs for cancer cell arrival by sending chemical signals ahead to create welcoming “pre-metastatic niches.”
  • Stomach cancer more commonly affects older people (average age 68) and men, with risk factors including H. pylori infection, diet high in preserved foods, smoking, and family history.
  • While cure is rarely possible for metastatic disease, treatment can control cancer growth, relieve symptoms, and improve quality of life, with treatment goals focused on prolonging life rather than cure.
  • Understanding the cellular and molecular mechanisms behind metastasis, such as decreased cell adhesion molecules and complex signaling pathways, offers promising perspectives for blocking cancer spread.